Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. May 16, 2023; 15(5): 407-419
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Figure 1 Flow diagram of patient selection.
IBD: Inflammatory bowel disease; EoE: Eosinophilic esophagitis.
Figure 2 Wilcoxon rank-sum test to assess fractional exhaled nitric oxide levels in eosinophilic esophagitis group compared to control.
FeNO: Fractional exhaled nitric oxide; EoE: Eosinophilic esophagitis.
Figure 3 Receiver operating characteristics analysis to predict fractional exhaled nitric oxide cut off.
ROC: Receiver operating characteristics; FeNO: Fractional exhaled nitric oxide; EoE: Eosinophilic esophagitis.
Figure 4 Spearman correlation analysis between fractional exhaled nitric oxide and esophageal eosinophils.
FeNO: Fractional exhaled nitric oxide; eos: Eosinophils.
- Citation: Kaur P, Chevalier R, Friesen C, Ryan J, Sherman A, Page S. Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils. World J Gastrointest Endosc 2023; 15(5): 407-419
- URL: https://www.wjgnet.com/1948-5190/full/v15/i5/407.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i5.407